A new dawn in cardio and vascular protection v. cardiovascular high-risk patients: treat to protect

Medscape J Med. 2008 Mar 26;10 Suppl(Supp):S1.

Authors

Toshiro Fujita¹, Giuseppe Mancia, Anne Jakobsen, Jose Heroys, Ann Ralph, Tomas Rees, Michael Shaw

Affiliation

¹ Department of Nephrology and Endocrinology, University of Tokyo School of Medicine, Tokyo, Japan. fujita-dis@h.u-tokyo.ac.jp

PMID: 18449383
PMCID: PMC2344121

No abstract available

MeSH terms

Angiotensin II Type 1 Receptor Blockers / therapeutic use*
Angiotensin-Converting Enzyme Inhibitors / therapeutic use*
Cardiotonic Agents / therapeutic use*
Cardiovascular Diseases / prevention & control*
Humans
Primary Prevention / trends*
Risk Factors

Substances

Angiotensin II Type 1 Receptor Blockers
Angiotensin-Converting Enzyme Inhibitors
Cardiotonic Agents